Emicizumab in Hemophilia A. Reply

Louis M. Aledort

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	786
Number of pages	1
Journal	New England Journal of Medicine
Volume	382
Issue number	8
DOIs	https://doi.org/10.1056/NEJMc1916299
State	Published - 20 Feb 2020

Access to Document

@article{da4a1eb58991413b86162ff1a6f48864,

title = "Emicizumab in Hemophilia A. Reply",

author = "Aledort, \{Louis M.\}",

year = "2020",

month = feb,

day = "20",

doi = "10.1056/NEJMc1916299",

language = "English",

volume = "382",

pages = "786",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "8",

}

TY - JOUR

T1 - Emicizumab in Hemophilia A. Reply

AU - Aledort, Louis M.

PY - 2020/2/20

Y1 - 2020/2/20

UR - https://www.scopus.com/pages/publications/85079810581

U2 - 10.1056/NEJMc1916299

DO - 10.1056/NEJMc1916299

M3 - Letter

C2 - 32074442

AN - SCOPUS:85079810581

SN - 0028-4793

VL - 382

SP - 786

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 8

ER -